Stock Events

Stock Events

Sana Biotechnology 

$3.65
199
-$0.04-0.95% 19:42 Today

Statistics

Day High
3.69
Day Low
3.58
52W High
6.55
52W Low
2.61
Volume
210,437
Avg. Volume
-
Mkt Cap
1.09B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.39
-0.31
-0.23
-0.15
Expected EPS
-0.147288
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-244.17MNet Income

Analyst Ratings

6.67Average Price Target
The highest estimate is 7.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SANA. It's not an investment recommendation.
Humacyte
40
HUMA
Quanterix
36
QTRX
Bitcoin
29
BTC.CRYPTO
NVIDIA
28
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics is focused on gene editing, directly competing with Sana's gene therapy and modification technologies.
Editas Medicine
EDIT
Mkt Cap433.1M
Editas Medicine operates in the CRISPR gene editing space, making it a direct competitor in gene therapy innovations.
Intellia Therapeutics
NTLA
Mkt Cap1.67B
Intellia Therapeutics is another key player in CRISPR gene editing, competing in the same space as Sana for gene therapy applications.
Beam Therapeutics
BEAM
Mkt Cap2.76B
Beam Therapeutics uses base editing, a form of gene editing, positioning it as a competitor in the gene therapy market.
Voyager Therapeutics
VYGR
Mkt Cap201.49M
Voyager Therapeutics specializes in gene therapy, particularly for neurological diseases, competing with Sana's gene therapy approaches.
PTC Therapeutics
PTCT
Mkt Cap5.98B
PTC Therapeutics operates in the field of genetic disorders, including gene therapy, making it a competitor in Sana's market.

About

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
Show more...
CEO
Steven D. Harr
Employees
142
Country
United States
ISIN
US7995661045

Listings

BOATS
BOATS
SANA.BOATS
XNAS
US
SANA

0 Comments

Share your thoughts

FAQ

What is Sana Biotechnology stock price today?▼
The current price of SANA is $3.65 USD — it has decreased by -0.95% in the past 24 hours. Watch Sana Biotechnology stock price performance more closely on the chart.
What is Sana Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Sana Biotechnology stocks are traded under the ticker SANA.
Is Sana Biotechnology stock price growing?▼
SANA stock has fallen by -3.83% compared to the previous week, the month change is a +15.71% rise, over the last year Sana Biotechnology has showed a +7.21% increase.
What is Sana Biotechnology market cap?▼
Today Sana Biotechnology has the market capitalization of 1.09B
When is the next Sana Biotechnology earnings date?▼
Sana Biotechnology is going to release the next earnings report on November 05, 2026.
What were Sana Biotechnology earnings last quarter?▼
SANA earnings for the last quarter are -0.22 USD per share, whereas the estimation was -0.15 USD resulting in a -49.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sana Biotechnology revenue for the last year?▼
Sana Biotechnology revenue for the last year amounts to 0 USD.
What is Sana Biotechnology net income for the last year?▼
SANA net income for the last year is -244.17M USD.
How many employees does Sana Biotechnology have?▼
As of August 18, 2026, the company has 142 employees.
In which sector is Sana Biotechnology located?▼
Sana Biotechnology operates in the Health & Wellness sector.
When did Sana Biotechnology complete a stock split?▼
Sana Biotechnology has not had any recent stock splits.
Where is Sana Biotechnology headquartered?▼
Sana Biotechnology is headquartered in SEATTLE, United States.